Pharmaceuticals New Zealand

New Zealand Erectile Dysfunction Treatment Market Analysis, 2024–2034

New Zealand Erectile Dysfunction Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $48.1 Mn Estimated value
Estimate 2025 $51.6 Mn 1% of the global market
Projected 2034 $97.2 Mn 88.5% Adds $45.7 Mn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 38% of 160 Pharmaceuticals markets here
Key players 5
  • New Zealand is 1% of the global market.
  • In APAC, the largest is China at $391.7 Mn.
  • Fastest growing: India at 9.7% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$45.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Erectile Dysfunction Treatment Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $48.1 Mn — —
2025 (base) $51.6 Mn +$3.5 Mn —
2026 (forecast) $55.3 Mn +$3.8 Mn +7.3%
2027 (forecast) $59.4 Mn +$4.0 Mn +15.1%
2028 (forecast) $63.7 Mn +$4.3 Mn +23.5%
2029 (forecast) $68.4 Mn +$4.7 Mn +32.6%
2030 (forecast) $73.4 Mn +$5.0 Mn +42.2%
2031 (forecast) $78.7 Mn +$5.4 Mn +52.6%
2032 (forecast) $84.5 Mn +$5.7 Mn +63.8%
2033 (forecast) $90.6 Mn +$6.2 Mn +75.7%
2034 (forecast) $97.2 Mn +$6.6 Mn +88.5%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $5.15 Bn
  2. North America $2.69 Bn
  3. US $2.09 Bn
  4. APAC $1.22 Bn
  5. Europe $868.8 Mn
  6. China $391.7 Mn
  7. Canada $357.7 Mn
  8. Japan $357.4 Mn
  9. Middle East $227.9 Mn
  10. Latin America $218.0 Mn
  11. Germany $158.1 Mn
  12. France $147.9 Mn
  13. Italy $126.8 Mn
  14. UK $121.8 Mn
  15. Brazil $124.1 Mn
  16. Spain $110.2 Mn
  17. Ecuador $104.9 Mn
  18. Saudi Arabia $102.9 Mn
  19. India $94.5 Mn
  20. Mexico $87.9 Mn
  21. Africa $84.6 Mn
  22. Australia $58.6 Mn
  23. New Zealand (this report) $51.6 Mn
  24. Russia $46.1 Mn
  25. South Africa $39.0 Mn
  26. UAE $23.6 Mn
  27. Egypt $13.6 Mn
  28. Philippines $11.4 Mn
  29. Hong Kong $8.6 Mn
  30. Malaysia $7.1 Mn
  31. Singapore $6.5 Mn
  32. Thailand $6.3 Mn
  33. Kenya $3.1 Mn

The New Zealand Erectile Dysfunction Treatment Market Analysis Executive Summary

Erectile dysfunction treatments include tablets, injections, devices and implants, increasingly prescribed through telehealth.

Key segments of the erectile Dysfunction Treatment market include treatment (PDE5 Inhibitors, Injectables and Vacuum Devices) and channel (Clinics, Telehealth and Pharmacies).

New Zealand Erectile Dysfunction Treatment Market Dynamics

Market Growth Drivers

An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the erectile Dysfunction Treatment market.

Opportunity

Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the erectile Dysfunction Treatment market room to grow.

Market Restraints

Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the erectile Dysfunction Treatment market.

Competitive Landscape for Erectile Dysfunction Treatment Market in New Zealand

The erectile Dysfunction Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Erectile Dysfunction Treatment Market in New Zealand

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for erectile Dysfunction Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Erectile Dysfunction Treatment right now, from free public sources.

Latest research 47 papers since 2021 (worldwide)

  1. Ulcerative Bullosis Diabeticorum in a Man With Chronic, Uncontrolled Diabetes, Uncontrolled Erectile Dysfunction, and Significant Social Barriers to Care. The American journal of case reports, 2026
  2. Gas signaling molecule: a new research focus in the treatment of erectile dysfunction. Medical gas research, 2026
  3. Men's Experiences and Decision-Making in Erectile Dysfunction Treatment: A Qualitative Evidence Synthesis. Cureus, 2026
  4. A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials. The journal of sexual medicine, 2026
  5. Sexual and reproductive health consequences of COVID-19 pandemic in Nigeria: an infodemiological survey. Scientific reports, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Erectile Dysfunction Treatment in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How much research is published on Erectile Dysfunction Treatment?
PubMed lists 47 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Erectile Dysfunction Treatment in New Zealand? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Men's Health Supplements: Beyond the MarketingOnly about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual… Fertility Services: Rising Demand and Access GapsAbout 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income. Hair Loss Treatments: What WorksIn 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in New Zealand

See all
Same topic, other categories

Related on men's health and kidney health

See the topic